Welcome to Medpharm Publications

Medpharm Publications was founded in 1988 and has established itself as the largest medical and pharmaceutical journal publisher in South Africa.

With a publications list of more than ten titles comprising of over fifty journal editions, Medpharm Publications reach more than 40 000 healthcare workers countrywide with printed editions, and has established a global audience with the online editions.

The majority of Medpharm Publications’ journals are associated with professional or scholarly societies and acts as the official South African mouthpiece in the associated discipline. All journals are web-based, most of which are fully peer-reviewed, with five titles accredited by the South African Department of Higher Education and Training (DHET) to earn research subsidies for academic departments.

As a publisher, passionate about journal publishing, we believe that South African researchers and clinicians can and will make a significant contribution to world medical literature.

Diabetes control demands earlier action

Diabetes is one of South Africa’s fastest-growing health challenges and is a leading cause of chronic illness, premature death and growing pressure on primary and specialist care services. Early detection and coordinated management are key to improving long-term outcomes.

Urgent Action to Combat South Africa’s ‘Silent Killer’ Through Patient Empowerment

Marking World Hypertension Month 2026, Servier South Africa is calling for a fundamental shift in how high blood pressure is addressed. Under the banner “Controlling Hypertension Together,” the organisation emphasises that improving outcomes depends on extending care beyond clinic settings and empowering patients to take an active role in managing their health.

SA healthcare startup secures R15 Million to expand access to affordable dental care

Mia Healthcare Technologies, founded in 2021 by Dr. Zane Stennings and Dr. Karishma Soni, has secured R 15 million in funding from the Vumela Fund to accelerate its mission of improving access to affordable dental and orthodontic care across Southern Africa. The business exemplifies the type of high-impact, growth-oriented enterprise that the fund seeks to support.

Cipla secures vaccine tender across key immunisation categories

Cape Town, May 2026 – Cipla has been awarded a public sector vaccine tender, reaffirming the company’s commitment to strengthening South Africa’s immunisation program through the equitable supply of high quality, affordable vaccines.

Africa CDC and Aspen advance long-term Vaccine Supply Partnership for Africa

Nairobi, Kenya | 12 May 2026 – Africa Centres for Disease Control and Prevention (“Africa CDC”) and Aspen Pharmacare (“Aspen”) are in advanced discussions on a long-term demand and supply alignment framework aimed at strengthening sustainable vaccine manufacturing in Africa.